Marco Pistis - Publications

Affiliations: 
Dept Neuroscience, Univ Cagliari, Cagliari, Sardegna, Italy 
Area:
Neurosciences

103/133 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sagheddu C, Cancedda E, Bagheri F, Kalaba P, Muntoni AL, Lubec J, Lubec G, Sanna F, Pistis M. The atypical dopamine transporter inhibitor CE-158 enhances dopamine neurotransmission in the prefrontal cortex of male rats: a behavioral, electrophysiological and microdialysis study. The International Journal of Neuropsychopharmacology. PMID 37725477 DOI: 10.1093/ijnp/pyad056  0.675
2023 Sagheddu C, Devoto P, Aroni S, Saba P, Pistis M, Gessa GL. Combined α- and D-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals. Frontiers in Pharmacology. 14: 1238115. PMID 37680715 DOI: 10.3389/fphar.2023.1238115  0.427
2023 Ferré S, Köfalvi A, Ciruela F, Justinova Z, Pistis M. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder. Trends in Pharmacological Sciences. PMID 37331914 DOI: 10.1016/j.tips.2023.05.003  0.412
2023 Santoni M, Sagheddu C, Serra V, Mostallino R, Paola Castelli M, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. Brain, Behavior, and Immunity. PMID 36746342 DOI: 10.1016/j.bbi.2023.02.002  0.778
2022 Murru E, Muntoni AL, Manca C, Aroni S, Pistis M, Banni S, Carta G. Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice. International Journal of Molecular Sciences. 24. PMID 36614161 DOI: 10.3390/ijms24010709  0.608
2022 Kouhnavardi S, Ecevitoglu A, Dragačević V, Sanna F, Arias-Sandoval E, Kalaba P, Kirchhofer M, Lubec J, Niello M, Holy M, Zehl M, Pillwein M, Wackerlig J, Murau R, Mohrmann A, ... ... Pistis M, et al. A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions. Biomolecules. 12. PMID 35883437 DOI: 10.3390/biom12070881  0.35
2022 Santoni M, Frau R, Pistis M. Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation. Frontiers in Pharmacology. 13: 821498. PMID 35211019 DOI: 10.3389/fphar.2022.821498  0.394
2021 Sagheddu C, Melis M, Muntoni AL, Pistis M. Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681249 DOI: 10.3390/ph14101025  0.723
2021 Congiu M, Micheli L, Santoni M, Sagheddu C, Muntoni AL, Makriyannis A, Malamas MS, Ghelardini C, Di Cesare Mannelli L, Pistis M. N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34553321 DOI: 10.1007/s13311-021-01116-4  0.646
2021 Lubec J, Kalaba P, Hussein AM, Feyissa DD, Kotob MH, Mahmmoud RR, Wieder O, Garon A, Sagheddu C, Ilic M, Dragačević V, Cybulska-Klosowicz A, Zehl M, Wackerlig J, Sartori SB, ... ... Pistis M, et al. Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition. Molecular Psychiatry. PMID 34244620 DOI: 10.1038/s41380-021-01214-x  0.304
2021 Pintori N, Castelli MP, Miliano C, Simola N, Fadda P, Fattore L, Scherma M, Ennas MG, Mostallino R, Flore G, De Felice M, Sagheddu C, Pistis M, Di Chiara G, De Luca MA. REPEATED EXPOSURE TO JWH-018 INDUCES ADAPTIVE CHANGES IN THE MESOLIMBIC AND MESOCORTICAL DOPAMINE PATHWAYS, GLIAL CELLS ALTERATION AND BEHAVIOURAL CORRELATES. British Journal of Pharmacology. PMID 33837969 DOI: 10.1111/bph.15494  0.34
2020 Murru E, Carta G, Manca C, Sogos V, Pistis M, Melis M, Banni S. Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation. Frontiers in Pharmacology. 11: 587140. PMID 33505308 DOI: 10.3389/fphar.2020.587140  0.449
2020 Sagheddu C, Torres LH, Marcourakis T, Pistis M. Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction. Frontiers in Synaptic Neuroscience. 12: 588660. PMID 33424577 DOI: 10.3389/fnsyn.2020.588660  0.368
2020 Devoto P, Sagheddu C, Santoni M, Flore G, Saba P, Pistis M, Gessa GL. Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex. Frontiers in Pharmacology. 11: 588160. PMID 33071798 DOI: 10.3389/fphar.2020.588160  0.439
2020 Sagheddu C, Pintori N, Kalaba P, Dragačević V, Piras G, Lubec J, Simola N, De Luca MA, Lubec G, Pistis M. Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer ()-CE-123 on Mesocorticolimbic Dopamine System. Biomolecules. 10. PMID 32443397 DOI: 10.3390/biom10050779  0.368
2019 Lecca S, Luchicchi A, Scherma M, Fadda P, Muntoni AL, Pistis M. Δ-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. Frontiers in Behavioral Neuroscience. 13: 202. PMID 31551729 DOI: 10.3389/Fnbeh.2019.00202  0.824
2019 Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, Wackerlig J, Langer T, Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, et al. The Novel Atypical Dopamine Uptake Inhibitor -CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. Frontiers in Pharmacology. 10: 682. PMID 31316379 DOI: 10.3389/fphar.2019.00682  0.426
2019 Congiu M, Trusel M, Pistis M, Mameli M, Lecca S. Opposite responses to aversive stimuli in lateral habenula neurons. The European Journal of Neuroscience. PMID 30860301 DOI: 10.1111/ejn.14400  0.461
2018 Torres LH, Balestrin NT, Spelta LEW, Duro SO, Pistis M, Marcourakis T. Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice. Toxicology Letters. 302: 35-41. PMID 30553937 DOI: 10.1016/j.toxlet.2018.12.002  0.34
2018 De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087  0.74
2018 Sagheddu C, Scherma M, Congiu M, Fadda P, Carta G, Banni S, Wood JT, Makriyannis A, Malamas MS, Pistis M. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward. Neuropharmacology. 144: 327-336. PMID 30439418 DOI: 10.1016/J.Neuropharm.2018.11.013  0.476
2018 Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y  0.628
2017 Pistis M, O'Sullivan SE. The Role of Nuclear Hormone Receptors in Cannabinoid Function. Advances in Pharmacology (San Diego, Calif.). 80: 291-328. PMID 28826538 DOI: 10.1016/bs.apha.2017.03.008  0.339
2017 Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863  0.721
2016 Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024  0.781
2016 Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/Ijnp/Pyw007  0.804
2016 Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/S00213-015-4196-3  0.715
2016 De Felice M, Aroni S, Muntoni A, Frau R, Fanni S, Pardu A, Devoto P, Pistis M. P.4.010 Effects of maternal immune activation on dopamine activity in male and female offspring European Neuropsychopharmacology. 26: S93-S94. DOI: 10.1016/S0924-977X(16)70100-3  0.64
2015 Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004  0.762
2015 Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26388146 DOI: 10.1038/Npp.2015.295  0.811
2015 Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/J.Neuropharm.2015.06.003  0.824
2015 Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, ... ... Pistis M, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/Nn.3892  0.53
2015 Melis M, Colombo G, Pistis M. SY02-3ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL Alcohol and Alcoholism. 50: i3.3-i4. DOI: 10.1093/ALCALC/AGV076.06  0.668
2014 Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/Jneurosci.1844-14.2014  0.788
2014 Melis M, Pistis M. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 86: 42-9. PMID 24704146 DOI: 10.1016/j.phrs.2014.03.009  0.574
2013 Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Frontiers in Integrative Neuroscience. 7: 93. PMID 24416004 DOI: 10.3389/Fnint.2013.00093  0.665
2013 Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nature Neuroscience. 16: 1652-61. PMID 24121737 DOI: 10.1038/Nn.3540  0.429
2013 Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541  0.748
2013 Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, ... ... Pistis M, et al. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6203-11. PMID 23554501 DOI: 10.1523/Jneurosci.4647-12.2013  0.835
2013 Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. Cns & Neurological Disorders Drug Targets. 12: 70-7. PMID 23394525 DOI: 10.2174/1871527311312010012  0.656
2013 Sagheddu C, Melis M, De Felice M, Colombo G, Pistis M. S.07.03 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S120-S121. DOI: 10.1016/S0924-977X(13)70147-0  0.51
2013 Sagheddu C, Melis M, Pistis M. P.1.024 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S22-S23. DOI: 10.1016/S0924-977X(13)70026-9  0.568
2012 Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3276-85. PMID 23108546 DOI: 10.1098/rstb.2011.0383  0.66
2012 Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 14094-101. PMID 23055478 DOI: 10.1523/Jneurosci.3370-12.2012  0.483
2012 Luchicchi A, Pistis M. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Molecular Neurobiology. 46: 374-92. PMID 22801993 DOI: 10.1007/S12035-012-8299-0  0.7
2012 Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1838-47. PMID 22453137 DOI: 10.1038/Npp.2012.31  0.749
2012 Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007  0.795
2012 Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/Npp.2011.302  0.857
2011 Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/Npp.2010.190  0.855
2011 Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, et al. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biological Psychiatry. 69: 633-41. PMID 20801430 DOI: 10.1016/J.Biopsych.2010.07.009  0.779
2010 Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biological Psychiatry. 68: 256-64. PMID 20570248 DOI: 10.1016/J.Biopsych.2010.04.016  0.658
2010 Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addiction Biology. 15: 277-88. PMID 20477753 DOI: 10.1111/J.1369-1600.2010.00222.X  0.851
2010 Fattore L, Melis M, Fadda P, Pistis M, Fratta W. The endocannabinoid system and nondrug rewarding behaviours. Experimental Neurology. 224: 23-36. PMID 20353776 DOI: 10.1016/J.Expneurol.2010.03.020  0.546
2010 Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Current Medicinal Chemistry. 17: 1450-67. PMID 20166922 DOI: 10.2174/092986710790980014  0.513
2010 Luchicchi A, Lecca S, Carta S, Pistis M. P.6.d.019 Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area European Neuropsychopharmacology. 20: S598-S599. DOI: 10.1016/S0924-977X(10)70913-5  0.733
2010 Lecca S, Luchicchi A, Carta S, Melis M, Muntoni A, Pistis M. P.6.d.018 Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus European Neuropsychopharmacology. 20: S598. DOI: 10.1016/S0924-977X(10)70912-3  0.781
2009 Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2  0.829
2009 Luchicchi A, Lecca S, Carta S, Pillolla G, Pistis M. P6.d.009 Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system European Neuropsychopharmacology. 19: S662-S663. DOI: 10.1016/S0924-977X(09)71068-5  0.726
2009 Luchicchi A, Pillolla G, Lecca S, Pistis M. P.4.08 Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat European Neuropsychopharmacology. 19: S86-S86. DOI: 10.1016/S0924-977X(09)70098-7  0.782
2008 Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/Jneurosci.3221-08.2008  0.837
2008 Fattore L, Fadda P, Spano MS, Pistis M, Fratta W. Neurobiological mechanisms of cannabinoid addiction. Molecular and Cellular Endocrinology. 286: S97-S107. PMID 18372102 DOI: 10.1016/J.Mce.2008.02.006  0.399
2008 Perra S, Pillolla G, Luchicchi A, Pistis M. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system. Alcoholism, Clinical and Experimental Research. 32: 443-9. PMID 18215217 DOI: 10.1111/J.1530-0277.2007.00588.X  0.81
2007 Melis M, Pistis M. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Current Neuropharmacology. 5: 268-77. PMID 19305743 DOI: 10.2174/157015907782793612  0.668
2007 Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. European Journal of Pharmacology. 573: 11-9. PMID 17644084 DOI: 10.1016/j.ejphar.2007.06.047  0.802
2007 Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z  0.847
2007 Pillolla G, Perra S, Melis M, Muntoni A, Pistis M. P.1.20 Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate European Neuropsychopharmacology. 17: S18. DOI: 10.1016/S0924-977X(07)70021-4  0.834
2006 Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/J.Nbd.2006.04.010  0.84
2006 Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x  0.832
2006 Pistis M, Perra S, Pillolla G, Muntoni A, Melis M. P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological study European Neuropsychopharmacology. 16: S496-S497. DOI: 10.1016/S0924-977X(06)70672-1  0.799
2005 Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0  0.829
2005 Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021  0.829
2004 Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/Jneurosci.3502-04.2004  0.841
2004 Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006  0.842
2004 Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004  0.829
2004 Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003  0.843
2003 Sanna A, Congeddu E, Porcella A, Saba L, Pistis M, Peis M, Marchese G, Ruiu S, Lobina C, Grayson DR, Gessa GL, Pani L. Characterization of wild-type (R100R) and mutated (Q100Q) GABAA alpha 6 subunit in Sardinian alcohol non-preferring rats (sNP). Brain Research. 967: 98-105. PMID 12650970 DOI: 10.1016/S0006-8993(02)04230-0  0.609
2002 Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research. 948: 155-8. PMID 12383968 DOI: 10.1016/S0006-8993(02)03055-X  0.678
2002 Castelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. European Journal of Pharmacology. 446: 1-5. PMID 12098579 DOI: 10.1016/S0014-2999(02)01713-2  0.588
2002 Pistis M, Muntoni AL, Pillolla G, Gessa GL. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. The European Journal of Neuroscience. 15: 1795-802. PMID 12081659 DOI: 10.1046/j.1460-9568.2002.02019.x  0.817
2001 Pistis M, Porcu G, Melis M, Diana M, Gessa GL. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. The European Journal of Neuroscience. 14: 96-102. PMID 11488953 DOI: 10.1046/j.0953-816X.2001.01612.x  0.835
2001 Saba L, Porcella A, Congeddu E, Colombo G, Peis M, Pistis M, Gessa GL, Pani L. The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. Brain Research. Molecular Brain Research. 87: 263-70. PMID 11245930 DOI: 10.1016/S0169-328X(01)00003-1  0.598
2000 Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 642-9. PMID 10788763 DOI: 10.1016/S0893-133X(00)00087-7  0.839
1999 Belelli D, Pistis M, Peters JA, Lambert JJ. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends in Pharmacological Sciences. 20: 496-502. PMID 10603492 DOI: 10.1016/S0165-6147(99)01405-4  0.311
1999 Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x  0.837
1999 Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 397: 359-63. PMID 9950429 DOI: 10.1038/16941  0.308
1999 Pistis M, Belelli D, McGurk K, Peters JA, Lambert JJ. Complementary regulation of anaesthetic activation of human (alpha6beta3gamma2L) and Drosophila (RDL) GABA receptors by a single amino acid residue. The Journal of Physiology. 515: 3-18. PMID 9925873 DOI: 10.1111/J.1469-7793.1999.003Ad.X  0.305
1997 Pistis M, Belelli D, Peters JA, Lambert JJ. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. British Journal of Pharmacology. 122: 1707-19. PMID 9422818 DOI: 10.1038/Sj.Bjp.0701563  0.3
1997 Pistis M, Muntoni AL, Gessa G, Diana M. Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience. 79: 171-6. PMID 9178873 DOI: 10.1016/S0306-4522(96)00643-4  0.827
1996 Diana M, Pistis M, Muntoni A, Gessa G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience. 71: 411-5. PMID 9053796 DOI: 10.1016/0306-4522(95)00482-3  0.819
1996 Diana M, Muntoni AL, Pistis M, Collu M, Forgione A, Gessa GL. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. European Journal of Pharmacology. 312: 179-81. PMID 8894593 DOI: 10.1016/0014-2999(96)00581-X  0.803
1995 Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. The Journal of Pharmacology and Experimental Therapeutics. 272: 781-5. PMID 7853194  0.83
1995 Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse (New York, N.Y.). 20: 153-5. PMID 7570345 DOI: 10.1002/syn.890200209  0.825
1995 Diana M, Pistis M, Muntoni AL, Gessa GL. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Research. 682: 29-34. PMID 7552323 DOI: 10.1016/0006-8993(95)00292-X  0.843
1995 Pistis M, Diana M, Muntoni AL, Maccioni F, Gessa GL. Reduction of mesolimbic dopaminergic activity outlasts ethanol withdrawal syndrome in rats Behavioural Pharmacology. 6: 90. DOI: 10.1097/00008877-199505001-00104  0.665
1995 Pistis M, Diana M, Muntoni AL, Palomba F, Gessa GL. Decrease of serotoninergic neuronal activity during ethanol withdrawal syndrome in rats Behavioural Pharmacology. 6: 89. DOI: 10.1097/00008877-199505001-00103  0.703
1995 Muntoni AL, Diana M, Pistis M, Maccioni F, Gessa GL. Long lasting reduction of mesolimbic dopaminergic neuronal activity after morphine withdrawal Behavioural Pharmacology. 6: 85. DOI: 10.1097/00008877-199505001-00100  0.719
1995 Diana M, Pistis M, Muntoni AL, Gessa GL. No reduction of spontaneously active mesolimbic dopaminergic neurons in ethanol withdrawn rats Behavioural Pharmacology. 6: 80. DOI: 10.1097/00008877-199505001-00094  0.729
1995 Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Effects of 7-OH-DPAT on the rat mesolimbic dopaminergic system Behavioural Pharmacology. 6: 71. DOI: 10.1097/00008877-199505001-00085  0.752
1995 Diana M, Pistis M, Muntoni AL, Collu M, Forgione A, Gossa GL. Plasticity changes in dopamine autoreceptor function after chronic L-sulpiride Behavioural Pharmacology. 6: 19. DOI: 10.1097/00008877-199505001-00020  0.769
1993 Diana M, Pistis M, Muntoni A, Gessa G. Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. European Journal of Pharmacology. 230: 363-5. PMID 8440312 DOI: 10.1016/0014-2999(93)90574-2  0.838
1993 Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proceedings of the National Academy of Sciences of the United States of America. 90: 7966-9. PMID 8367449 DOI: 10.1073/Pnas.90.17.7966  0.776
1992 Diana M, Pistis M, Muntoni A, Rossetti ZL, Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. European Journal of Pharmacology. 221: 403-4. PMID 1426019 DOI: 10.1016/0014-2999(92)90734-L  0.814
1992 Diana M, Pistis M, Muntoni A, Gessa GL. Electrophysiological effects of acute and chronic ethanol administration Pharmacological Research. 26: 216. DOI: 10.1016/1043-6618(92)91142-4  0.748
Low-probability matches (unlikely to be authored by this person)
1999 Belelli D, Pistis M, Peters JA, Lambert JJ. The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochemistry International. 34: 447-52. PMID 10397373 DOI: 10.1016/S0197-0186(99)00037-6  0.287
1998 McGurk KA, Pistis M, Belelli D, Hope AG, Lambert JJ. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor. British Journal of Pharmacology. 124: 13-20. PMID 9630337 DOI: 10.1038/Sj.Bjp.0701787  0.281
2013 Costa M, Squassina A, Congiu D, Chillotti C, Niola P, Galderisi S, Pistis M, Del Zompo M. Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 749-59. PMID 22920733 DOI: 10.1016/j.euroneuro.2012.07.007  0.244
2016 Pistis M. Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems European Neuropsychopharmacology. 26: S116. DOI: 10.1016/S0924-977X(16)30877-X  0.241
2020 Torres LH, Real CC, Turato WM, Spelta LW, Dos Santos Durão ACC, Andrioli TC, Pozzo L, Squair PL, Pistis M, de Paula Faria D, Marcourakis T. Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain F-FDG Uptake From Infancy to Early Adulthood - A Longitudinal Study. Frontiers in Neuroscience. 14: 5. PMID 32063826 DOI: 10.3389/fnins.2020.00005  0.24
2023 Lubec J, Hussein AM, Kalaba P, Feyissa DD, Arias-Sandoval E, Cybulska-Klosowicz A, Bezu M, Stojanovic T, Korz V, Malikovic J, Aher NY, Zehl M, Dragacevic V, Leban JJ, Sagheddu C, ... ... Pistis M, et al. Low-Affinity/High-Selectivity Dopamine Transport Inhibition Sufficient to Rescue Cognitive Functions in the Aging Rat. Biomolecules. 13. PMID 36979402 DOI: 10.3390/biom13030467  0.239
2022 Palmas MF, Etzi M, Pisanu A, Camoglio C, Sagheddu C, Santoni M, Manchinu MF, Pala M, Fusco G, De Simone A, Picci L, Mulas G, Spiga S, Scherma M, Fadda P, ... Pistis M, et al. The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex. Cells. 11. PMID 36078036 DOI: 10.3390/cells11172628  0.226
2015 Pistis M, Loi A, Dabard MP. Influence of relative sea-level variations on the genesis of palaeoplacers, the examples of Sarrabus (Sardinia, Italy) and the Armorican Massif (western France) Comptes Rendus - Geoscience. DOI: 10.1016/j.crte.2015.09.006  0.218
2017 Andreucci S, Pistis M, Funedda A, Loi A. Semi-isolated, flat-topped carbonate platform (Oligo-Miocene, Sardinia, Italy): Sedimentary architecture and processes Sedimentary Geology. 361: 64-81. DOI: 10.1016/J.SEDGEO.2017.09.012  0.208
2020 Telesca D, Longhitano SG, Pistis M, Pascucci V, Tropeano M, Sabato L. Sedimentology of a transgressive middle-upper Miocene succession filling a tectonically confined, current dominated seaway (the Logudoro Basin, northern Sardinia, Italy) Sedimentary Geology. 400: 105626. DOI: 10.1016/J.Sedgeo.2020.105626  0.208
2002 Paoletti AM, Pilloni M, Orrù M, Floris S, Pistis M, Guerriero S, Ajossa S, Melis GB. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. Maturitas. 42: 137-47. PMID 12065173 DOI: 10.1016/S0378-5122(02)00030-0  0.205
2017 Longhitano SG, Telesca D, Pistis M. Tidal sedimentation preserved in volcaniclastic deposits filling a peripheral seaway embayment (early Miocene, Sardinian Graben) Marine and Petroleum Geology. 87: 31-46. DOI: 10.1016/J.Marpetgeo.2017.05.007  0.204
2017 Meloni MA, Oggiano G, Funedda A, Pistis M, Linnemann U. Tectonics, ore bodies, and gamma-ray logging of the Variscan basement, southern Gennargentu massif (central Sardinia, Italy) Journal of Maps. 13: 196-206. DOI: 10.1080/17445647.2017.1287601  0.204
2015 Puligheddu M, Pistis M, Melis M, Muntoni A, Pillola G, Marrosu F, Milioli G, Riccardi S, Orlandini F, Parrino L. Effective add-on treatment with fenofibrate in patients with nocturnal frontal lobe epilepsy Sleep Medicine. 16: S41. DOI: 10.1016/J.SLEEP.2015.02.099  0.202
2015 Dabard MP, Loi A, Paris F, Ghienne JF, Pistis M, Vidal M. Sea-level curve for the Middle to early Late Ordovician in the Armorican Massif (western France): Icehouse third-order glacio-eustatic cycles Palaeogeography, Palaeoclimatology, Palaeoecology. 436: 96-111. DOI: 10.1016/j.palaeo.2015.06.038  0.197
2018 Afrasinei GM, Melis MT, Arras C, Pistis M, Buttau C, Ghiglieri G. Spatiotemporal and spectral analysis of sand encroachment dynamics in southern Tunisia European Journal of Remote Sensing. 51: 352-374. DOI: 10.1080/22797254.2018.1439343  0.194
2023 Mostallino R, Santoni M, Sagheddu C, Serra V, Orrù V, Pistis M, Castelli MP. The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia. European Journal of Pharmacology. 961: 176172. PMID 37939988 DOI: 10.1016/j.ejphar.2023.176172  0.15
2023 Manca C, Coa R, Murru E, Carta G, Pinna G, Sanfilippo R, Polizzi L, Pistis M, Follesa P, Puligheddu M, Banni S. Identification of Metabolic Biomarkers of Chronic Vagus Nerve Stimulation (VNS) in Subjects with Drug-Resistant Epilepsy (DRE). Epilepsia Open. PMID 38016924 DOI: 10.1002/epi4.12871  0.141
2022 Murru E, Carta G, Manca C, Saebo A, Santoni M, Mostallino R, Pistis M, Banni S. Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and -Acylethanolamine Profiles. Frontiers in Nutrition. 9: 834066. PMID 35360687 DOI: 10.3389/fnut.2022.834066  0.102
2021 Pala D, Pistis M. Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology. Frontiers in Pharmacology. 12: 622554. PMID 33767626 DOI: 10.3389/fphar.2021.622554  0.09
1994 Marongiu F, Sorano GG, Bibbò C, Pistis MP, Conti M, Mulas P, Balestrieri A, Biggio P. Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology (Basel, Switzerland). 189: 32-7. PMID 7516205 DOI: 10.1159/000246755  0.06
2022 Ussai S, Pistis M, Missoni E, Formenti B, Armocida B, Pedrazzi T, Castelli F, Monasta L, Lauria B, Mariani I. "Immuni" and the National Health System: Lessons Learnt from the COVID-19 Digital Contact Tracing in Italy. International Journal of Environmental Research and Public Health. 19. PMID 35742778 DOI: 10.3390/ijerph19127529  0.046
2022 Ussai S, Castelpietra G, Mariani I, Casale A, Missoni E, Pistis M, Monasta L, Armocida B. What Is Next for Public Health after COVID-19 in Italy? Adopting a Youth-Centred Care Approach in Mental Health Services. International Journal of Environmental Research and Public Health. 19. PMID 36429653 DOI: 10.3390/ijerph192214937  0.03
2004 Paoletti AM, Congia S, Lello S, Tedde D, Orrù M, Pistis M, Pilloni M, Zedda P, Loddo A, Melis GB. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 62: 301-3. PMID 14745075  0.024
2022 Ussai S, Chillotti C, Stochino E, Deidda A, Ambu G, Anania L, Boccalini A, Colombo F, Ferrari A, Pala D, Puddu E, Rapallo G, Pistis M. Building the Momentum for A Stronger Pharmaceutical System in Africa. International Journal of Environmental Research and Public Health. 19. PMID 35328999 DOI: 10.3390/ijerph19063313  0.024
2013 Pistis M, Andreucci S, Funedda A, Loi A. Paleo-bay tidal deposits in central-south Sardinia (Italy) during Late Oligocene-Early Miocene Journal of Mediterranean Earth Sciences. 5: 127.  0.023
2008 Pistis M, Loi A, Dabard MP, Melis E, Leone F. Stacking Pattern and composition of shelf deposits: Heavy minerals enrichment (placers) of the Ordovician of Sardinia and Brittany | Relazione tra architettura deposizionale e composizione nei depositi di piattaforma terrigena: Gli accumuli a minerali pesanti (placers) dell' Ordoviciano della Sardegna e della Bretagna Rendiconti Online Societa Geologica Italiana. 3: 643-644.  0.02
2017 Afrasinei G, Melis MT, Buttau C, Arras C, Pistis M, Zerrim A, Guied M, Ouessar M, Essifi B, Zaied MB, Jlali A, Jarray H, Ghiglieri G. Classification methods for detecting and evaluating changes in desertification-related features in arid and semiarid environments Euro-Mediterranean Journal For Environmental Integration. 2. DOI: 10.1007/s41207-017-0021-1  0.015
2022 Armocida B, Formenti B, Ussai S, Missoni E, De Marchi C, Panella M, Onder G, Mancini L, Pistis M, Martuzzi M, Barone-Adesi F. Decarbonization of the Italian healthcare system and European funds. A lost opportunity? Frontiers in Public Health. 10: 1037122. PMID 36589995 DOI: 10.3389/fpubh.2022.1037122  0.01
2022 Armocida B, Ussai S, Pavlovych M, Valente M, Missoni E, Pistis M, Lauria B, Bustreo F, Onder G. Older people: forgotten victims amid the Ukrainian humanitarian disaster. The Lancet. Public Health. 7: e402-e403. PMID 35397205 DOI: 10.1016/S2468-2667(22)00087-1  0.01
Hide low-probability matches.